Autopsy report · NCT02309736

OTX-14-002: Device Exposure Registry

“On going discussions with FDA”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Ocular Therapeutix, Inc.

Sponsor type

Industry

Conditions

Endophthalmitis

Interventions

ReSure Sealant

Participants

0

Trials that died the same way

• MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly
  “FDA hold on the project” (73% match in meaning)
• Perceval S Aortic Heart Valve Study- North America
  “FDA approval” (72% match in meaning)
• Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
  “FDA reviewing” (71% match in meaning)
• Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma
  “Based on FDA requirements” (67% match in meaning)
• Safety of SP-420 in the Treatment of Transfusional Iron Overload
  “Study is on hold by FDA in the US.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.